دورية أكاديمية
أعرض في EDS

Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism.

التفاصيل البيبلوغرافية
العنوان: Mild COVID-19 Illness as a Risk Factor for Venous Thromboembolism.
المؤلفون: Clavijo MM; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Vicente Reparaz MLA; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Ruiz JI; Internal Medicine, Hospital Aleman, Buenos Aires, ARG., Acuña MA; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Casali CE; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Aizpurua MF; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Mahuad CV; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG., Eciolaza S; Hematology, Hospital Aleman, Buenos Aires, ARG., Ventura A; Hematology, Hospital Aleman, Buenos Aires, ARG., Garate GM; Hematology and Oncology, Hospital Aleman, Buenos Aires, ARG.
المصدر: Cureus [Cureus] 2021 Sep 24; Vol. 13 (9), pp. e18236. Date of Electronic Publication: 2021 Sep 24 (Print Publication: 2021).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Introduction From the beginning of the current coronavirus disease 2019 (COVID-19) pandemic, there is cumulative evidence suggesting that patients hospitalized due to this disease are at a high risk for venous thromboembolism (VTE). The association between mild non-hospitalized illness and VTE is unclear. The purpose of this research is to assess the association between VTE and mild COVID-19 infection. Methods A case-control study was conducted. The cases were adult patients diagnosed with VTE from March 1, 2020 to March 31, 2021. The controls were randomly chosen adult patients who required healthcare services that were equivalent to those of the cases, for any cause, during the same time period, without a VTE diagnosis. To assess the association between mild COVID and VTE, a multivariate logistic regression analysis was conducted, considering other thromboembolic risk variables, such as age, gender and active cancer, among others. A p-value <0.05 was considered statistically significant. Results A total of 186 cases and 475 controls were analyzed. There were 21 (11.3%) and 31 (6.5%) patients infected with mild COVID-19 in the previous three months in the groups of cases and controls, respectively. Mild COVID-19 infection was statistically significant as a risk factor for VTE both in the univariate analysis and in the multivariate analysis, OR=1.82 (95% CI 1.02-3.26) and OR=2.62 (95% CI 1.34-5.13), respectively. Conclusion Mild COVID-19 infection might be an independent risk factor for VTE. We conclude that the results suggest some thromboprophylaxis strategy should be considered in certain patients with COVID-19 infection in an outpatient fashion.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2021, Clavijo et al.)
References: Am J Case Rep. 2020 Jul 22;21:e925786. (PMID: 32694498)
Cureus. 2021 Feb 7;13(2):e13207. (PMID: 33717746)
J Am Heart Assoc. 2021 Feb 2;10(3):e019650. (PMID: 33228447)
PLoS One. 2020 Aug 21;15(8):e0238160. (PMID: 32822430)
Thromb Res. 2020 Aug;192:3-8. (PMID: 32407937)
BMJ Case Rep. 2020 Sep 16;13(9):. (PMID: 32938654)
Lupus. 2021 Jan;30(1):172-174. (PMID: 33092468)
Cureus. 2020 Oct 28;12(10):e11213. (PMID: 33269143)
Anesth Analg. 2020 Nov;131(5):1324-1333. (PMID: 33079850)
Res Pract Thromb Haemost. 2020 Sep 25;:. (PMID: 33043231)
Cureus. 2021 Jan 28;13(1):e12953. (PMID: 33654625)
Thromb Res. 2020 Oct;194:116-118. (PMID: 32788102)
Int J Infect Dis. 2021 Mar;104:77-82. (PMID: 33352324)
Eur Heart J Case Rep. 2020 Oct 01;4(5):1-5. (PMID: 33200109)
Blood Adv. 2021 Feb 9;5(3):872-888. (PMID: 33560401)
J Surg Case Rep. 2020 Sep 30;2020(9):rjaa343. (PMID: 33024534)
BMJ Case Rep. 2021 Jan 7;14(1):. (PMID: 33414129)
Thromb Res. 2020 Aug;192:27-28. (PMID: 32419710)
Ann Acad Med Singap. 2021 Feb;50(2):188-190. (PMID: 33733266)
Respir Res. 2020 Jul 3;21(1):169. (PMID: 32620118)
Cureus. 2020 Sep 10;12(9):e10349. (PMID: 33062472)
Am Surg. 2021 May 28;:31348211023416. (PMID: 34049454)
Thromb J. 2021 Jan 6;19(1):1. (PMID: 33407578)
Chest. 2021 Mar;159(3):1182-1196. (PMID: 33217420)
فهرسة مساهمة: Keywords: coronavirus disease 2019 (covid-19); deep vein thrombosis (dvt); mild covid-19 infection; pulmonary embolism; risk factor for vte; venous thromboembolism (vte)
تواريخ الأحداث: Date Created: 20211101 Latest Revision: 20211102
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC8544806
DOI: 10.7759/cureus.18236
PMID: 34722035
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.18236